Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Thorac Cardiovasc Surg ; 162(3): 710-720.e1, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32713631

RESUMO

OBJECTIVES: Because patients' preoperative nutritional status influences the outcomes, we have used a preoperative nutrition program for surgical patients for a 2-year period and compared the results with those from a cohort treated in the previous 2 years. METHODS: We retrospectively reviewed curative thoracic neoplasm resections from July 15, 2016, to July 15, 2018, in patients who had received a preoperative nutritional-enhanced recovery after surgery (N-ERAS) protocol. The protocol consisted of 5 days of an oral immunonutrition drink 3 times daily, daily receipt of probiotics, and a carbohydrate-loading drink the night before surgery. The historical control cohort (standard group) included those patients who had undergone surgery by the same surgeon during the previous 24 months. We excluded patients who had undergone esophageal, diagnostic, benign, emergency, or palliative procedures. Nonparametric and parametric statistical tests were used to analyze the data. RESULTS: The data from 462 patients were analyzed: 229 N-ERAS patients and 233 standard patients. No significant demographic or caseload differences were found between the 2 groups. The major significant outcome differences included fewer postoperative complications (30 [13.1%] in the N-ERAS group vs 60 [25.8%] in the standard group; P < .001) and shorter hospital stays (3.8 ± 1.9 days for the N-ERAS group vs 4.4 ± 2.6 days for the standard group; P = .001). Use of the N-ERAS protocol resulted in a 16% reduction ($2198; P < .001) in the mean direct hospital costs/patient. Consequently, for the N-ERAS cohort, the hospital was likely saved $503,342 during the 2-year period for the 229 patients just by using the N-ERAS protocol. CONCLUSIONS: Thoracic surgeons should consider using the nontoxic, patient-compliant N-ERAS protocol for their patients, with an expectation of improved clinical results at lower hospital costs-an important consideration when exploring methods to decrease costs because hospitals are increasingly being paid by a negotiated prospective bundled payment reimbursement model.


Assuntos
Recuperação Pós-Cirúrgica Melhorada , Estado Nutricional , Apoio Nutricional , Cuidados Pré-Operatórios , Neoplasias Torácicas/cirurgia , Procedimentos Cirúrgicos Torácicos , Idoso , Bebidas , Redução de Custos , Análise Custo-Benefício , Carboidratos da Dieta/administração & dosagem , Feminino , Alimentos Formulados , Estado Funcional , Custos Hospitalares , Humanos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Apoio Nutricional/efeitos adversos , Apoio Nutricional/economia , Valor Nutritivo , Cuidados Pré-Operatórios/efeitos adversos , Cuidados Pré-Operatórios/economia , Probióticos/administração & dosagem , Recuperação de Função Fisiológica , Estudos Retrospectivos , Neoplasias Torácicas/economia , Procedimentos Cirúrgicos Torácicos/efeitos adversos , Fatores de Tempo , Resultado do Tratamento
2.
J Thorac Oncol ; 11(8): 1224-1232, 2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-27079184

RESUMO

There is growing interest for economic evaluation in oncology to illustrate the value of multiple new diagnostic and therapeutic interventions. As these analyses have started to move from specialist publications into mainstream medical literature, the wider medical audience consuming this information may need additional education to evaluate it appropriately. Here we review standard practices in economic evaluation, illustrating the different methods with thoracic oncology examples where possible. When interpreting and conducting health economic studies, it is important to appraise the method, perspective, time horizon, modeling technique, discount rate, and sensitivity analysis. Guidance on how to do this is provided. To provide a method to evaluate this literature, a literature search was conducted in spring 2015 to identify economic evaluations published in the Journal of Thoracic Oncology. Articles were reviewed for their study design, and areas for improvement were noted. Suggested improvements include using more rigorous sensitivity analyses, adopting a standard approach to reporting results, and conducting complete economic evaluations. Researchers should design high-quality studies to ensure the validity of the results, and consumers of this research should interpret these studies critically on the basis of a full understanding of the methodologies used before considering any of the conclusions. As advancements occur on both the research and consumer sides, this literature can be further developed to promote the best use of resources for this field.


Assuntos
Oncologia/economia , Neoplasias Torácicas/economia , Análise Custo-Benefício , Árvores de Decisões , Humanos , Cadeias de Markov , Publicações Periódicas como Assunto/economia , Anos de Vida Ajustados por Qualidade de Vida , Projetos de Pesquisa
3.
Chirurg ; 80(11): 1053-8, 2009 Nov.
Artigo em Alemão | MEDLINE | ID: mdl-19685033

RESUMO

Due to the higher incidence of malignant tumours with increasing age, cancer is the second most common cause of death among those aged over 65 years old. Consequently, demographic changes in Germany have resulted in a rising demand for oncological operations in elderly patients which is more cost-intensive. Objective of the present study in the setting of a university surgical department is whether oncological operations on patients over 80 years old is cost-effective in the era of diagnosis-related groups. The revenue and expenditure of 116 cases of patients over 80 years old documented for the years 2005-2007 were collated and evaluated. The calculated average proceeds were compared with cases of patients under 80 years old.The average return was -1493.50 EUR/case for over 80-year olds and was not cost-effective. The presence or absence of complications had a significant impact on proceeds, because the mean return/case without complications was profitable (1297.30 EUR). Medical care of patients over 80 years old was on average cost-effective and generated a profit. Oncological operations in patients under 80 years old were not sufficiently remunerated by the current DRG system. Therefore, there is an economical risk associated with oncological operations in elderly patients.


Assuntos
Neoplasias Abdominais/economia , Neoplasias Abdominais/cirurgia , Grupos Diagnósticos Relacionados/economia , Programas Nacionais de Saúde/economia , Neoplasias Torácicas/economia , Neoplasias Torácicas/cirurgia , Neoplasias Abdominais/mortalidade , Idoso , Idoso de 80 Anos ou mais , Comorbidade , Análise Custo-Benefício/economia , Custos e Análise de Custo , Alemanha , Custos Hospitalares/estatística & dados numéricos , Mortalidade Hospitalar , Humanos , Unidades de Terapia Intensiva/economia , Tempo de Internação/economia , Complicações Pós-Operatórias/economia , Mecanismo de Reembolso/economia , Neoplasias Torácicas/mortalidade
6.
Radiology ; 148(1): 65-7, 1983 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-6856866

RESUMO

All patients who were admitted over a two-year period for evaluation of undiagnosed intrathoracic masses were selected for study. We assessed the impact of thin needle aspiration biopsy (TNAB) of thoracic lesions on actual hospital charges and patterns of patient care. Findings of TNAB reduced the need for diagnostic thoracotomy, shortened the time from admission to diagnosis, reduced the total number of thoracotomies, shortened the length of the hospital stay, and resulted in a significantly reduced average and total hospitalization charge.


Assuntos
Biópsia por Agulha/métodos , Honorários e Preços , Neoplasias Torácicas/economia , Broncoscopia , Honorários e Preços/tendências , Humanos , Tempo de Internação , Mediastinoscopia , Escarro/citologia , Neoplasias Torácicas/patologia , Neoplasias Torácicas/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...